The importance of TSC1/TSC2 in the control of mTORC1 is revealed in tuberous sclerosis patients, where functional loss of either TSC1 or TSC2 results in non-metastatic tumors (reviewed in 10). This evidence concerns the gene TSC2 and tuberous sclerosis.